PhRMA defines the word “chutzpah”

  • Pharmaceutical and biotechnology sales revenue increased from $534 billion to $775 billion between 2006 and 2015. Additionally, 67% of drug companies increased their annual profit margins during the same period—with margins up to 20 percent for some companies in certain years. (Source: GAO)
  • Pharmaceutical companies continue to rake in the highest profit margins.
  • Eight of the 15 highest net profit margins were at drug companies.
  • Yet PhRMA has launched a social media campaign to point the finger at hospitals.

Continue reading

PhRMA winning the PR war on drug pricing

  • The amount of money people spend on prescription drugs has nearly doubled since the 1990s.
  • According to the GAO “pharmaceutical and biotechnology sales revenue increased from $534 billion to $775 billion between 2006 and 2015. Additionally, 67% of drug companies increased their annual profit margins during the same period—with margins up to 20 percent for some companies in certain years”.
  • Pharmaceutical companies have some of the highest profit margins in the world, a distinction that has earned the industry criticism from both politicians and consumers, who often complain about the high prices of prescription drugs
  • PhRMA launched a PR campaign to blame PBM’s for high drug prices and it seems to be working.

Continue reading

PhRMA defines chutzpah

(PhRMA) president and CEO Stephen J. Ubl issued the following statement on President Donald Trump’s drug pricing blueprint: “These far-reaching proposals could fundamentally change how patients access medicines and realign incentives across the entire prescription drug supply chain. While some of these proposals could help make medicines more affordable for patients, others would disrupt coverage and limit patients’ access to innovative treatments”. Folks, that is chutzpah. Continue reading